Adolescent attitudes toward psychiatric medication: The utility of the Drug attitude inventory

Journal of Child Psychology and Psychiatry and Allied Disciplines

Volumn 50, Issue 12, 2009, Pages 1523-1531

  Townsend, Lisa ^a   Floersch, Jerry ^a   Findling, Robert L ^b  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Adolescence; Drug Attitude Inventory; Medication; Mental health; Psychopharmacology; Structural equation modeling

Indexed keywords

NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD BEHAVIOR; CORRELATION ANALYSIS; DEVELOPMENTAL STAGE; DRUG ATTITUDE INVENTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREDICTION; STRUCTURAL EQUATION MODELING; SUBSTANCE ABUSE; SUICIDE ATTEMPT; TREATMENT DURATION;

ADOLESCENT; ADOLESCENT BEHAVIOR; ATTITUDE TO HEALTH; CHILD; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PATIENT COMPLIANCE; PSYCHOTROPIC DRUGS; QUESTIONNAIRES;

EID: 70449106426     PISSN: 00219630     EISSN: 14697610     Source Type: Journal    
DOI: 10.1111/j.1469-7610.2009.02113.x     Document Type: Article

References (40)

1. Ajzen, I. Fishbein, M. (1980). Understanding attitudes and predicting social behavior. New Jersey : Prentice-Hall.
2. Bernstein, G.A., Anderson, L.K., Hektner, J.M. Realmuto, G.M. (2000). Imipramine adherence in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 284 291.
3. Birmaher, B. Axelson, D. (2006). Course and outcome of bipolar spectrum disorder in children and adolescents: A review of the existing literature. Development and Psychopathology, 18, 1023 1035.
4. Brook, O., van Hout, H., Nieuwenhuyse, H. Heerdink, E. (2003). Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients: A randomized controlled trial. European Neuropsychopharmacology, 13, 1 9.
5. Brown, R.T., Borden, K.A. Clingerman, S.R. (1985). Adherence to methylphenidate therapy in a pediatric population: A preliminary investigation. Psychopharmacology Bulletin, 21, 28 36.
6. Browne, M.W. Cudeck, R. (1993). Alternative ways of assessing model fit. In K.A. Bollen J.S. Long Eds Testing structural equation models (pp. 136 162.). Newbury Park, CA : Sage.
7. Chen, E.Y.H., Tam, D.K.P., Wong, J.W.S., Law, C.W. Chiu, C.P.Y. (2005). Self-administered instrument to measure the patient's experience of recovery after first episode psychosis: Development and validation of the Psychosis Recovery Inventory. Australian and New Zealand Journal of Psychiatry, 39, 493 499.
8. Christian, Pagano, Demeter, McNamara, Lingler, Bedoya, Faber Findling 2008). Poster Presentation. Presented at the American Academy of Child and Adolescent Psychiatry annual meeting, Chicago, IL.
9. Cromer, B.A. Tarnowski, K.J. (1989). Non-adherence in adolescents: A review. Developmental and Behavioral Pediatrics, 10, 207 215.
10. Donohoe, G., Owens, N., O'Donnell, C., Burke, T., Moore, L., Tobin, A. O'Callaghan (2001). Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: A discriminant function analysis. European Psychiatry, 16, 293 298.
11. Efron, D., Jarman, F.C. Barker, M.J. (1998). Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder. Journal of Paediatric Child Health, 34, 288 292.
12. Fenton, W.S., Blyler, C.R. Heinssen, R.K. (1997). Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin, 23, 637 651.
13. Ferguson (1976). Statistical analysis in psychology and education (4th edn). New York : McGraw-Hill.
14. Floersch, J., Townsend, L., Longhofer, J., Munson, M., Winbush, V., Kranke, D., Faber, R., Thomas, J., Jenkins, J. Findling, R.L. (in press). Adolescent experience of psychotropic treatment. Transcultural Psychiatry.
15. Fortney, J., Rost, K., Zhang, M. Pyne, J. (2001). The relationship between quality and outcome in routine depression care. Psychiatric Services, 52, 56 62.
16. Gao, K., Kemp, D.E., Ganocy, S.J., Gajwani, P., Xia, G. Calabrese, J. (2008). Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: A systematic review. Journal of Clinical Psychopharmacology, 28, 203 209.
17. Geller, B., Tillman, R., Craney, J.L. Bolhofner, K. (2004). Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Archives of General Psychiatry, 61, 459 467. (Pubitemid 38620844)
18. Gervin, M., Browne, S., Garavan, J., Roe, M., Larkin, C. O'Callaghan, E. (1999). Dysphoric subjective response to neuroleptics in schizophrenia: Relationship to extrapyramidal side effects and symptomatology. European Psychiatry, 14, 405 409.
19. Hogan, T.P., Awad, A.G. Eastwood, R. (1983). A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine, 13, 177 183.
20. Ingoldsby, E.M., Kohl, G.O., McMahon, R.J. Lengua, L. (2006). Conduct problems, depressive symptomatology and their co-occurring presentation in childhood as predictors of adjustment in early adolescence. Journal of Abnormal Child Psychology, 34, 603 621.
21. Jeste, S.D., Patterson, T.L., Palmer, B.W., Dolder, C.R., Goldman, S. Jeste, D.V. (2003). Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophrenia Research, 63, 49 58.
22. Kampman, O., Lehtinen, K., Lassila, V., Leinonen, E., Poutanen, O. Koivisto, A.M. (2000). Attitudes towards neuroleptic treatment: Reliability and validity of the Attitudes towards Neuroleptic Treatment (ANT) questionnaire. Schizophrenia Research, 45, 223 234.
23. Kaplan, D. (2000). Structural equation modeling: Foundations and extensions. Thousand Oaks, CA : Sage.
24. Karow, A., Schnedler, D. Naber, D. (2006). What would the patient choose? Subjective comparison of atypical and typical neuroleptics. Pharmacopsychiatry, 39, 47 51.
25. Little, T. (2006). Structural equation modeling: Foundations and extended applications. June 4-8, University of Kansas Quantitative Training Program.
26. Lloyd, A., Horan, W., Borgaro, S.R., Stokes, J.M., Pogge, D.L. Harvey, P.D. (1998). Predictors of medication adherence after hospital discharge in adolescent psychiatric patients. Journal of the American Academy of Child and Adolescent Psychiatry, 8, 133 141.
27. Muller-Oerlinghausen, B., Muser-Causemann, B. Volk, J. (1992). Suicides and parasuicides in a high risk patient group on and off lithium long-term treatment. Journal of Affective Disorders, 25, 261 269.
28. Naber, D. (1995). A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, and other clinical variables. International Clinical Psychopharmacology, 10 (Suppl. 3 133 138.
29. Pae, C.U., Lee, K.U., Kim, J.J., Lee, C.U., Bahk, W.M., Lee, S.J., Lee, C. Paik, I.H. (2004). Switching to quetiapine in patients with acute mania who were intolerant to risperidone. Human Psychopharmacology and Clinical Experiments, 19, 47 51.
30. Ritsner, M., Perelroyzen, G., Ilan, H. Gibel, A. (2004). Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice. Journal of Clinical Psychopharmacology, 24, 245 254.
31. Rossi, A., Arduini, L., Stratta, P. Pallanti, S. (2000). Subjective experience and subjective response to neuroleptics in schizophrenia. Comprehensive Psychiatry, 41, 446 449.
32. Sajatovic, M., Davies, M. Hrouda, D.R. (2004). Enhancement of treatment adherence among patients with bipolar disorder. Psychiatric Services, 55, 264 269.
33. Schimmelmann, B.G., Paulus, S., Schacht, M., Tilgner, C., Schulte-Markwort, M. Lambert, M. (2005). Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics. Journal of Child and Adolescent Psychopharmacology, 15, 249 258.
34. Sibitz, L., Katschnig, H., Goessler, R., Unger, A. Amering, M. (2005). Pharmacophilia and pharmacophobia: Determinants of patients' attitudes towards antipsychotic medication. Pharmacopsychiatry, 38, 107 112.
35. Sleator, E.K. (1985). Measurement of adherence. Psychopharmacology Bulletin, 21, 1089 1093.
36. Sleator, E.K., Ullman, R.K. von Neumann, A. (1982). How do hyperactive children feel about taking stimulants and will they tell the doctor? Clinical Pediatrics, 21, 474 479.
37. Spector, P. (1992). Summated rating scale construction: An introduction (QASS07-082). Newbury Park, CA : Sage.
38. Swanson, J. (2003). Adherence with stimulants for attention deficit/hyperactivity disorder: Issues and approaches for improvement. CNS Drugs, 17, 117 131.
39. Weiden, P. Glazer, W. (1997). Assessment and treatment selection for 'revolving door' inpatients with schizophrenia. Psychiatric Quarterly, 68, 377 392.
40. Weiden, P.J. Olfson, M. (1995). Cost of relapse in schizophrenia. Schizophrenia Bulletin, 23, 419 429.